Scrophularia deserti
Scrophularia deserti · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Scrophularia deserti is a botanical species noted for its unique chemical profile and therapeutic potential. Research has identified key bioactive compounds within the plant, specifically harpagoside and harpagoside B. When utilized in the form of concentrated extracts, these chemical constituents may offer significant physiological benefits. Current studies highlight its promising antidiabetic properties, suggesting a role in managing blood sugar levels. This plant represents a compelling subject for further pharmacological exploration in natural medicine.
- Synonyms
- Scrophularia Deserti Var. Foliata · Scrophularia Moniliformis · 1 more
- Common names
- Not available
- Family
- Scrophulariaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Scrophularia deserti is a botanical species characterized by several taxonomic synonyms that reflect its complex classification history. Researchers have previously identified this plant under various names, including the variety Scrophularia deserti var. foliata. Additionally, the names Scrophularia moniliformis and Scrophularia sinaica have been utilized to describe specimens belonging to this group. These overlapping designations highlight the evolving nature of botanical nomenclature as scientists refine their understanding of the species. Understanding these relationships is essential for maintaining accurate records within plant databases and scientific literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Scrophularia deserti is a distinct member of the kingdom Plantae. Within this vast botanical realm, it is classified under the class Equisetopsida. The plant further belongs to the order Lamiales, showcasing its evolutionary connections. It is more specifically nested within the family Scrophulariaceae. Finally, this species is defined by its placement in the genus Scrophularia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Scrophulariaceae |
| Genus | Scrophularia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Scrophularia deserti is a resilient species with a geographic range spanning across diverse arid regions. Its distribution begins in Northern Africa, where it can be found throughout Egypt. The plant also thrives across the temperate zones of Asia, specifically throughout the Arabian Peninsula. Within this peninsula, it is documented in several key locations including Kuwait, Oman, and Saudi Arabia. Furthermore, its presence extends into the various Gulf States, marking it as a significant part of the regional flora.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Scrophularia deserti is a self-supporting herb that grows upright in its natural habitat. This sturdy growth form allows the plant to maintain its structure without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Scrophularia deserti is a plant known to contain several significant iridoid glycosides within its aerial parts. Chemical analysis has identified the presence of koelzioside and scropolioside D in this species. Furthermore, the plant contains harpagoside, a compound that was previously identified through structural revisions. Research also highlights the presence of harpagoside B, which is noted for its anti-inflammatory properties. Together, these various chemical constituents contribute to the complex profile of Scrophularia deserti.
Conditions
Scrophularia deserti possesses significant antidiabetic and antiinflammatory activities, which are attributed to iridoid glycosides such as scropolioside-D and harpagoside-B. This plant is also recognized for its ability to treat digestive disorders within ethnoveterinary applications. Furthermore, research has demonstrated that Scrophularia deserti exhibits persistent hypoglycaemic effects in animal models. Finally, the species is utilized for the treatment of ophthalmic disorders.
Preparations
Scrophularia deserti is prepared as extracts to evaluate its potential medicinal properties. These extracts were specifically administered orally to both normal and alloxanised rats during a study on Egyptian desert plants. The research focused on testing the hypoglycaemic activity of these plant preparations compared to a standard drug. Through this process, the extracts of Scrophularia deserti were found to exhibit persistent hypoglycaemic effects. This method of preparation allowed researchers to observe the plant's impact on blood glucose levels in various animal models.